A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Clinical trial NCT02301897 · COMPLETED
Trial details
- NCT number
- NCT02301897
- Sponsor
- Repros Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-16
- Primary completion
- 2017-06-02
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.